CAP-1002 Allogeneic Cardiosphere-Derived Cells
1002-01
Phase 2 mab terminated
Quick answer
CAP-1002 Allogeneic Cardiosphere-Derived Cells for Myocardial Infarction is a Phase 2 program (mab) at CAPRICOR THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CAPRICOR THERAPEUTICS, INC.
- Indication
- Myocardial Infarction
- Phase
- Phase 2
- Modality
- mab
- Status
- terminated